期刊文献+

老年晚期非小细胞肺癌预后的影响因素分析 被引量:5

Factors Prognostic of Advanced Non-Small-Cell Lung Cancers in the Elderly
在线阅读 下载PDF
导出
摘要 目的:研究对老年晚期肺癌预后的影响因素。方法:回顾性分析2000年1月-2006年6月中山大学肿瘤防治中心内科接受一线化疗的年龄≥70岁的晚期肺癌(IIIb或IV期)患者共99例,总结其临床资料、实验室检查并随访其生存情况。结果:99例老年晚期非小细胞肺癌患者中位生存期:10.0月[95%置信区间:(6.7,13.3)月],1年生存率:41.2%,对临床特点、实验室检查、治疗模式等共15个可能预后因素进行单因素分析,显示:临床分期、体重下降、PS评分、肝转移、乳酸脱氢酶(LDH)、血红蛋白水平(Hgb)、伴随疾病与预后相关。多因素分析显示:PS评分>1、LDH升高、血红蛋白<110g/L、肝转移是老年晚期非小细胞肺癌的不良预后因素。结论:PS评分、LDH、血红蛋白水平和肝转移可能是老年晚期非小细胞肺癌患者的独立预后因素。 Objective:To identify factors prognostic of advanced non-small-cell lung cancers (NSCLCs) in the elderly. Methods: We retrospectively reviewed 99 patients (aged 70 years old or above) with advanced NSCLCs (stage Ⅲb or Ⅳ ) who received first-line chemotherapy at the Department of Medical Oncology, Sun Yat-Sen University Cancer Center, between January 2000 and July 2006. Data on their clinical features, laboratory findings and survival at follow-up were evaluated. Results: Of all 99 patients, the median length of survival was 10.0 months (95% confidence interval, 6.6 to 13.3 months) and the one-year survival rate was 41.2%. Univariate analysis including 15 potential factors revealed that clinical stages, weight loss, PS score, liver metastasis, LDH, level of hemoglobin ( Hgb), comorbidity correlated significantly with the survival. In multivariate analysis, PS score 〉 1, elevated LDH, Hgb 〈 110g/L and liver metastasis were factors significantly unfavorable for prognosis in elderly NSCLC. Conclusion: PS score, LDH, Hgb and liver metastasis may be independent factors prognostic of advanced non-small-cell lung cancer in the elderly.
出处 《广州医学院学报》 2007年第5期48-52,共5页 Academic Journal of Guangzhou Medical College
关键词 老年 非小细胞肺癌 生存 预后 elderly non-small-cell lung cancer survival prognosis
作者简介 彭晋(1979.10-),男,医学硕士。研究方向:肺癌的化学治疗。 通讯作者:Tel:(020)-87343423,E-mail:drwhy@163.net
  • 相关文献

参考文献10

  • 1Ries LAG,Melbert D,Krapeho M,et al.SEER Cancer Statistics Review 1975-2004[OL].http://seer,cancer.gov/csr/1975-2004/.
  • 2Oken MM,Creech RH,Tormey DC,et al.Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group[J].Am J Clin Oncol,1982,5(6):649-655.
  • 3Finkelstein DM,Ettinger DS,Ruckdeschel JC.Long-term survivors in metastatic non-small-cell lung cancer:an Eastern Cooperative Oncology Group Study[J].J Clin Oncol,1986,4(5):702-709.
  • 4Albain KS,Crowley J,LeBlanc M,et al.Survival determinants in extensive-stage non-small-cell lung cancer:the Southwest Oneology Group experience[J].J Clin Oncol,1991,9(9):1618-1626.
  • 5Hoang T,Xu R,Schiller JH,et al.Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative ontology group data[J].J Clin Oncol,2005,23 (1):175-183.
  • 6Wisnivesky JP,Halm EA.Sex differences in lung cance survival:do tumors behave differently in elderly women[J].J Clin Oncol,2007,25 (13):1705-1712.
  • 7Mollerup S,Ryberg D,Hewer A,et al.Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients[J].Cancer Res,1999,59 (14):3317 -3320.
  • 8Lord RV,Brabender J,Gandara D,et al.Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer[J].Clin CancerRes,2002,8 (7):2286-2291.
  • 9Yovino S,Kwok Y,Krasna M,et al.An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone[J].Int J Radiat Oncol Biol Phys,2005,62 (5):1438-1443.
  • 10Dempkc W.Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer[J].Anticaneer Res,2007,27 (4A):1745-1757.

同被引文献36

  • 1邵亚娟,王颖轶,孟长婷,王毓洲.小细胞肺癌77例治疗及预后分析[J].中国医学科学院学报,2010,32(4):394-397. 被引量:18
  • 2GeofreyC.Kabat.美国吸烟者与非吸烟者肺癌流行病学概况[J].肿瘤,1996,16(4):457-466. 被引量:12
  • 3程刚.非小细胞肺癌的分子靶向药物治疗[J].中华肿瘤防治杂志,2007,14(5):387-390. 被引量:6
  • 4Yang L, Li LD, Cheng YD, et al. Estimation and prediction of incidence and mortality of malignant tumors in China in the year of 2000 and 2005. Chin Hygiene Statistics, 2005, 92(4):218-221.
  • 5Bunn PA Jr, Litenbann R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer lnst, 2003, 95(5):341-343.
  • 6Jazieh AR, Hussain M, Howington JA, et al. Prognostic factors in patients with surgically resected stages I and 11 non-small cell lung cancer. Ann Thorac Surg, 2000, 70(4): 1168-1171.
  • 7Tartari RF, Ulbrich-Kulczynski JM, Filho AF. Measurement of mid-arm muscle circumference and prognosis in stage IV non-small cell lung cancer patients. Oncol Lett, 2013, 5(3): 1063-1067.
  • 8Hoang T, Xu RH, Schiller HS, et al. Clinical model to predict survival in chemonaive patients with advanced non-small cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data. J Clin Onco, 2005, 23(1):175-183.
  • 9Yang L,Li LD,Cheng YD,et al.Estimation and prediction of incidence and mortality of malignant tumors in China in the year of 2000 and 2005[J].Chin Hygiene Statistics,2005,22 (4):218-221.
  • 10Tartarr RF,Ulbrich-Kulczynski JM,Filho AF.Measurement of mid-arm muscle circumference and prognosis in stage Ⅳ non-small cell lung cancer patients[J].Oncol Lett,2013,5 (3):1063-1067.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部